At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Transaortic TAVR Implant +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
In Brief
A clinical study evaluating Transaortic TAVR Implant and Subclavian /Axillary TAVR implant for Aortic Valve Stenosis. Completed, enrolled 64 participants across 10 sites in 5 countries.
Detailed Summary
Expand the indication of the Portico TF Delivery System and obtain approval of the Alternative Access Delivery System
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis
CountriesDenmark, Germany, Italy, Netherlands, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartMar 2017
Primary CompletionDec 2018
Study CompletionJul 2019
TodayJul 2026
First PostedFeb 17, 2017
Enrollment StartMar 29, 2017
Primary CompletionDec 31, 2018
Study CompletionJul 5, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.4 years ago
Interventions
Transaortic TAVR Implantdevice
Transaortic TAVR implant
Subclavian /Axillary TAVR implantdevice
Subclavian /Axillary TAVR implant